Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Sells Massarray to Whitehead Institute

NEW YORK, Jan 4 - MIT's Whitehead Institute has purchased Sequenom’s MassArray system for use in its high-throughput SNP genotyping projects, Sequenom said Thursday.

Sequenom spokesman Tom Baker said that the company has delivered a single MassArray system along with a number of consumables.

Baker declined to comment on the purchase price of the system.

The MassArray system eliminates the fluorescent tagging step that is necessary with competing SNP detection technologies, simplifying the detection process, said Baker.

The Whitehead Institute is the latest in a series of Human Genome Project contributors to purchase Sequenom’s technology, joining the National Human Genome Research Institute, the Sanger Centre in the U. K. and Germany’s National Research Center for Environment and Health.

Sequenom has also sold the MassArray to Hitachi, Gemini Genomics, Invitrogen, Ag Research Limited of New Zealand, Genaissance Pharmaceuticals, Integrated DNA technologies, American Home Products, and Metabion GmbH among other companies.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.